monoclonal antibody

Paul MK, Choudhary MC, Heaps AL, Deo R, Moisi D, Gordon KC, Mellors JW, Moser C, Klekotka P, Landay A, Currier JS, Eron JJ, Chew[...]

By sjmartinez • September 9, 2024

Yang Y, Konrad RJ, Ploug M, Young SG. APOA5 Deficiency Causes Hypertriglyceridemia by Reducing Amounts of Lipoprotein Lipase in Capillaries. J Lipid Res. 2024 Jun[...]

By sjmartinez • June 17, 2024

Pardridge WM. Receptor-mediated drug delivery of bispecific therapeutic antibodies through the blood-brain barrier. Front Drug Deliv. 2023;3:1227816. doi: 10.3389/fddev.2023.1227816. Epub 2023 Jul 10. PMID: 37583474;[...]

By sjmartinez • August 16, 2023

Pardridge WM. Brain gene therapy with Trojan horse lipid nanoparticles. Trends Mol Med. 2023 Mar 10:S1471-4914(23)00036-9. doi: 10.1016/j.molmed.2023.02.004. Epub ahead of print. PMID: 36907687.

By sjmartinez • March 13, 2023

Boado RJ. IgG Fusion Proteins for Brain Delivery of Biologics via Blood-Brain Barrier Receptor-Mediated Transport. Pharmaceutics. 2022 Jul 15;14(7):1476. doi: 10.3390/pharmaceutics14071476. PMID: 35890374; PMCID: PMC9322584.

By rosaguerrero • July 28, 2022